secwatch / observer
8-K filed March 16, 2026, 7:59 PM ET CIK 0001540013
M&A confidence high sentiment neutral materiality 0.95

Quipt Home Medical Corp.: M&A transaction — Quipt Home Medical completes going-private acquisition by Kingswood/Forager for $3.65/share, ~$173M total

Quipt Home Medical Corp.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.99

Quipt Home Medical Corp. underwent a change of control involving REM Aggregator, LLC and 1567208 B.C. Ltd. for US$3.65 per Share in cash, aggregate consideration approximately $173 million (closed 2026-03-16).

Action
change of control
Counterparty
REM Aggregator, LLC and 1567208 B.C. Ltd.
Consideration
US$3.65 per Share in cash, aggregate consideration approximately $173 million
Closing
2026-03-16
Exact text from the filing
Arrangement Agreement, among other things, the Purchaser acquired all of the issued and outstanding common shares (collectively, the “Shares”) of Quipt on the Closing Date for US$3.65 per Share in cash (the “Consideration”), by way of a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”). “Shares”) of Quipt on the
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Quipt Home Medical Corp. amended amendment to that certain amended and restated credit and guaranty agreement with First-Citizens Bank & Trust Company (effective 2026-03-13).

Action
amendment
Agreement
credit facility
Counterparty
First-Citizens Bank & Trust Company
Effective
2026-03-13
Exact text from the filing
On March 13, 2026, Parent entered into an amendment to that certain amended and restated credit and guaranty agreement, initially dated as of September 16, 2022
View on SEC.gov

Browse all m&a transactions →

Source: SEC EDGAR
accession 0001104659-26-027980
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.